MBRX · Moleculin Biotech, Inc.
$2.14
+0.04 (+1.90%)
At close · Jul 20
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$11.42M
Shares
5.34M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Walter Klemp | CEO | $1,458,759 |
| Jonathan Foster | CFO | $989,639 |
| Donald Picker | Chief Scientific Officer | $694,062 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Walter Klemp | CEO | $1,414,598 |
| Jonathan Foster | CFO | $840,642 |
| Donald Picker | Chief Scientific Officer | $599,106 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Walter Klemp | CEO | $1,971,080 |
| Jonathan Foster | CFO | $1,092,252 |
| Donald Picker | Chief Scientific Officer | $699,469 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Walter Klemp | CEO | $1,987,313 |
| Jonathan Foster | CFO | $1,149,177 |
| Donald Picker | Chief Scientific Officer | $682,397 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Walter Klemp | CEO | $1,516,779 |
| Jonathan Foster | CFO | $946,594 |
| Donald Picker | Chief Scientific Officer | $520,327 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Walter Klemp | CEO | $1,801,716 |
| Jonathan Foster | CFO | $838,941 |
| Donald Picker | Chief Scientific Officer | $522,189 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Walter Klemp | CEO | $1,345,675 |
| Jonathan Foster | CFO | $845,689 |
| Donald Picker | Chief Scientific Officer | $439,407 |